Yantai Zhenghai Bio-Tech Co Ltd (300653) — Working Capital to Net Assets Ratio
Yantai Zhenghai Bio-Tech Co Ltd (300653) has a Working Capital to Net Assets ratio of 72.3% as of September 2025. Working capital of CN¥632.08 Million (current assets of CN¥712.18 Million minus current liabilities of CN¥80.10 Million) is measured against net assets of CN¥874.47 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See debt-free asset ratio of Yantai Zhenghai Bio-Tech Co Ltd to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Yantai Zhenghai Bio-Tech Co Ltd Working Capital to Net Assets (2012–2024)
This chart shows how Yantai Zhenghai Bio-Tech Co Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2012 to 2024. As of September 2025, the ratio stands at 72.3%, reflecting working capital of CN¥632.08 Million against net assets of CN¥874.47 Million CNY. Check 300653 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Yantai Zhenghai Bio-Tech Co Ltd (2012–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Yantai Zhenghai Bio-Tech Co Ltd from 2012 to 2024, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Yantai Zhenghai Bio-Tech Co Ltd.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 71.1% | CN¥631.91 Million | CN¥888.78 Million | CN¥712.70 Million | CN¥80.79 Million | ▼ -0.7 pp |
| 2023 | 71.8% | CN¥680.63 Million | CN¥948.07 Million | CN¥770.63 Million | CN¥90.00 Million | ▲ +1.9 pp |
| 2022 | 69.9% | CN¥604.39 Million | CN¥865.11 Million | CN¥710.01 Million | CN¥105.61 Million | ▲ +1.4 pp |
| 2021 | 68.4% | CN¥537.35 Million | CN¥785.27 Million | CN¥663.38 Million | CN¥126.03 Million | ▲ +9.3 pp |
| 2020 | 59.1% | CN¥382.13 Million | CN¥646.72 Million | CN¥527.08 Million | CN¥144.95 Million | ▼ -10.8 pp |
| 2019 | 69.9% | CN¥411.16 Million | CN¥588.38 Million | CN¥525.46 Million | CN¥114.29 Million | ▼ -17.8 pp |
| 2018 | 87.7% | CN¥464.04 Million | CN¥529.00 Million | CN¥504.99 Million | CN¥40.96 Million | ▼ -0.4 pp |
| 2017 | 88.1% | CN¥425.56 Million | CN¥483.18 Million | CN¥456.45 Million | CN¥30.89 Million | ▲ +14.2 pp |
| 2016 | 73.8% | CN¥168.48 Million | CN¥228.16 Million | CN¥188.31 Million | CN¥19.83 Million | ▼ -11.1 pp |
| 2015 | 85.0% | CN¥152.48 Million | CN¥179.40 Million | CN¥165.82 Million | CN¥13.34 Million | ▲ +19.8 pp |
| 2014 | 65.2% | CN¥41.46 Million | CN¥63.62 Million | CN¥49.71 Million | CN¥8.25 Million | ▲ +40.0 pp |
| 2013 | 25.2% | CN¥7.38 Million | CN¥29.34 Million | CN¥43.20 Million | CN¥35.82 Million | ▼ -295.9 pp |
| 2012 | 321.1% | CN¥-20.65 Million | CN¥-6.43 Million | CN¥58.49 Million | CN¥79.13 Million | — |